- Home
- PC vs MBRX Comparison
PC vs MBRX Comparison
Compare PC & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PC
- MBRX
- Stock Information
- Founded
- PC 2012
- MBRX 2015
- Country
- PC Singapore
- MBRX United States
- Employees
- PC N/A
- MBRX N/A
- Industry
- PC Restaurants
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- PC Consumer Discretionary
- MBRX Health Care
- Exchange
- PC Nasdaq
- MBRX Nasdaq
- Market Cap
- PC 11.7M
- MBRX 12.9M
- IPO Year
- PC 2024
- MBRX 2016
- Fundamental
- Price
- PC $0.66
- MBRX $0.31
- Analyst Decision
- PC
- MBRX Strong Buy
- Analyst Count
- PC 0
- MBRX 3
- Target Price
- PC N/A
- MBRX $5.33
- AVG Volume (30 Days)
- PC 347.3K
- MBRX 5.2M
- Earning Date
- PC 02-15-2025
- MBRX 08-13-2025
- Dividend Yield
- PC N/A
- MBRX N/A
- EPS Growth
- PC N/A
- MBRX N/A
- EPS
- PC N/A
- MBRX N/A
- Revenue
- PC $3,345,964.00
- MBRX N/A
- Revenue This Year
- PC N/A
- MBRX N/A
- Revenue Next Year
- PC N/A
- MBRX N/A
- P/E Ratio
- PC N/A
- MBRX N/A
- Revenue Growth
- PC N/A
- MBRX N/A
- 52 Week Low
- PC $0.60
- MBRX $0.25
- 52 Week High
- PC $5.73
- MBRX $4.71
- Technical
- Relative Strength Index (RSI)
- PC N/A
- MBRX 24.39
- Support Level
- PC N/A
- MBRX $0.25
- Resistance Level
- PC N/A
- MBRX $0.42
- Average True Range (ATR)
- PC 0.00
- MBRX 0.06
- MACD
- PC 0.00
- MBRX -0.03
- Stochastic Oscillator
- PC 0.00
- MBRX 13.07
About PC Premium Catering (Holdings) Limited Ordinary Shares
Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.